Fresenius Citrasate Liquid Acid Concentrate Recalled for Discoloration
Fresenius Medical Care is recalling Citrasate Liquid Acid Concentrate for Bicarbonate Hemodialysis due to complaints of blue-green discoloration.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard is a cosmetic defect (discoloration) with no reported injuries or illnesses, fitting the criteria for a moderate severity score.
Plain-English summary
Fresenius Medical Care Renal Therapies Group, LLC is recalling Citrasate, Liquid Acid Concentrate for Bicarbonate Hemodialysis. The recall involves specific product numbers and lot numbers, including 08-2251-CA, 08-3251-CA, and 13-2251-CA.
The recall was initiated due to complaints of blue-green discoloration in the product. The affected units were distributed worldwide, including the United States and Mexico.
Healthcare facilities and consumers should stop using the affected lots and contact the manufacturer for further instructions.
The recalled product
- Product
- Citrasate, Liquid Acid Concentrate for Bicarbonate Hemodialysis: Product Numbers: 08-2251-CA, 08-3251-CA, 13-2251-CA; Liquid Acid Concentrate for Bicarbonate Hemodialysis
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- 1) 08-2251-CA
- UDI/DI 00840861101344
- Lot Numbers: 26BXAC038
- 2) 08-3251-CA
- UDI/DI 00840861101351
- Lot Numbers: 26BXAC039
- 3) 13-2251-CA
- UDI/DI 00840861101375
- Lot Numbers: 26BXAC040
- 26BXAC041.
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Fresenius Medical Care Renal Therapies Group, LLC
See all →- ModerateFresenius CombiSet Hemodialysis Blood Tubing Set Recalled for Handling Review
FDA (Devices) · 2026-09-30
- SevereFresenius Medical Care Recalls 5008X Standard HD Pre-Flush Blood Tubing Sets
FDA (Devices) · 2026-09-09
- ModerateFresenius NaturaLyte Liquid Acid Concentrate Recalled for Discoloration
FDA (Devices) · 2026-09-09
- SevereFresenius 5008X HD/HDF Blood Tubing Set Recalled for Leak Risk
FDA (Devices) · 2026-09-09
- HighFresenius Recalls Granuflo Dry Acid Concentrate Due to Discoloration
FDA (Devices) · 2026-09-09
Same hazard · discoloration
See all →- HighICU Medical Recalls IV Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
- SevereShilpa Medicare Recalls Discolored Pemetrexed Injection Vials
FDA (Drugs) · 2026-08-26
- ModerateShilpa Medicare Recalls Discolored PEMRYDI RTU Injection Vials
FDA (Drugs) · 2026-08-26
- ModeratePantoprazole Sodium Tablets Recalled for Discoloration Issues
FDA (Drugs) · 2026-04-29
- ModerateTavaborole topical solution recalled from three lots because of discoloration
FDA (Drugs) · 2025-10-22
Similar recalls
- ModerateFresenius NaturaLyte Liquid Acid Concentrate Recalled for Discoloration
FDA (Devices) · 2026-09-09
- HighFresenius Citrasate Liquid Acid Concentrate Recalled for Conductivity Deviation
FDA (Devices) · 2021-01-20
- HighFresenius Recalls Granuflo Dry Acid Concentrate Due to Discoloration
FDA (Devices) · 2026-09-09
- SevereFresenius Citrasate Liquid Acid Concentrate Recall Due to Low Sodium Levels
FDA (Devices) · 2021-01-20
- HighFresenius Citrasate Liquid Acid Concentrate Recalled for Low Sodium and Calcium Levels
FDA (Devices) · 2021-01-20
- SevereFresenius Citrasate Liquid Acid concentrate drums recalled for low sodium levels
FDA (Devices) · 2021-01-20